Dr Scott Plotkin

Crizotinib-radiation therapy combination may help preserve hearing in NF2

Adding the targeted cancer therapy drug crizotinib to radiation therapy…

6 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)

Adding the targeted cancer therapy drug crizotinib to radiation therapy for tumours associated with the genetic disorder neurofibromatosis 2 may reduce the hearing damage that can be exacerbated by radiotherapy...